IL-27 Receptor: A Critical Regulator of T Cell Development and Function
IL-27 Receptor: A Critical Regulator of T Cell Development and Function
The IL-27 receptor is a protein that is expressed in many different tissues throughout the body, including immune cells, peripheral tissues, and various organs. It is a member of the IL-27 family of cytokine receptors, which are a group of transmembrane proteins that play a critical role in the regulation of cellular responses to cytokines.
IL-27 is a cytokine that is produced by various cell types in response to the presence of an infection or injury. It has been shown to play a crucial role in the recruitment of immune cells to the site of inflammation and in the regulation of inflammation itself. IL-27 has also been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.
The IL-27 receptor is a G protein-coupled receptor, which means that it consists of a transmembrane protein that is linked to an intracellular signaling pathway. The IL-27 receptor is composed of two transmembrane subunits, which are held together by a disulfide bond. The subunits of the IL-27 receptor include an extracellular domain, a transmembrane domain, and an intracellular domain.
The IL-27 receptor is involved in a wide range of physiological processes in the body. It has been shown to play a role in the regulation of immune responses, including the regulation of T cell development and function. IL-27 has also been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.
One of the main functions of the IL-27 receptor is to regulate the activity of T cells. T cells are a type of immune cell that play a critical role in the regulation of various cellular processes in the body. T cells are produced in the bone marrow and are characterized by their ability to recognize and respond to specific antigens. T cells are important for the regulation of immune responses, including the regulation of infection and inflammation.
IL-27 has been shown to play a critical role in the regulation of T cell development and function. When an antigen is present in the body, T cells are recruited to the site of the antigen. Once recruited, T cells are able to recognize the antigen and become activated. Activated T cells then begin to divide and differentiate into other types of immune cells, including effector T cells and memory T cells.
IL-27 has also been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival. When T cells are activated, they begin to divide and differentiate into other types of immune cells. This process is critical for the development and function of the immune system. IL-27 has been shown to regulate the activity of T cells in a variety of ways, including the regulation of cell growth, differentiation, and survival.
In addition to its role in the regulation of T cells, IL-27 has also been shown to play a critical role in the regulation of other cellular processes in the body. For example, IL-27 has been shown to play a role in the regulation of inflammation. When an immune cell is activated, it produces a variety of cytokines, including IL-1 and IL-6. These cytokines can stimulate the production of other immune cells and can contribute to the regulation of inflammation.
IL-27 has also been shown to play a role in the regulation of pain. When an individual is injured or in pain, IL-27 is produced by various cell types in the body. This cytokine can stimulate the production of other immune cells and can contribute to the regulation of pain.
Despite its critical role in numerous physiological processes in the body, the IL-27 receptor is not yet widely targeted as a drug
Protein Name: IL-27 Receptor
The "IL-27 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL-27 receptor comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
IL-3 receptor | IL-31 Receptor | IL-4 receptor | IL-5 receptor | IL-6 receptor | IL10 | IL10RA | IL10RB | IL10RB-DT | IL11 | IL11RA | IL12A | IL12A-AS1 | IL12B | IL12RB1 | IL12RB2 | IL13 | IL13RA1 | IL13RA2 | IL15 | IL15RA | IL16 | IL17A | IL17B | IL17C | IL17D | IL17F | IL17RA | IL17RB | IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4
